AzuR: announced a positive result of MS1819 during phase 2 trials, by assessing MS1819 along with porcine-derived pancreatic enzyme replacement therapy for treating severe exocrine pancreatic insufficiency in patients with cystic fibrosis.
DiaSysDiagnostic Systems GmH announced the development of Lipase DC FS, a state-of-the-art direct colorimetric assay, with improved stability for Pancreatic Diagnosis.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?